early interest mix hiv drugs called lopinavir ritonavir flagged clinical trial nearly 200 people not find benefit mix severe covid-19 promising therapeutic hypothesis inhibiting action immune system regulator called il-6 met mixed results far host therapies tested people researchers hunting new drugs bench sheahan colleagues found compound active sars cov-2 coronaviruses including remdesivir resistant variant coronavirus tested laboratory grown human cells testing need compound tried people hopefully impact current pandemic says maybe importantly position better respond quickly future heidi ledford works magazine april 16 2020 tanya lewis april 7 2020 michael waldholz february 28 2020 tanya lewis june 1 2020